SUV-based features from baseline 2-[F-18]FDG-PET/CT in breast cancer patients differentiate tumor phenotypes but do not predict pathologic response to neoadjuvant chemotherapy

C. Oliveira; F. Oliveira; C. Constantino; H. Pinto Marques; F. Cardoso

SUV-based features from baseline 2-[F-18]FDG-PET/CT in breast cancer patients differentiate tumor phenotypes but do not predict pathologic response to neoadjuvant chemotherapy

C. Oliveira, F. Oliveira, C. Constantino, H. Pinto Marques, F. Cardoso

NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S150-S151
Journal	European Journal Of Nuclear Medicine And Molecular Imaging
Volume	49
Issue number	SUPPL 1
Publication status	Published - Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{da4499876c334a6ba309d07c80336452,

title = "SUV-based features from baseline 2-[F-18]FDG-PET/CT in breast cancer patients differentiate tumor phenotypes but do not predict pathologic response to neoadjuvant chemotherapy",

author = "C. Oliveira and F. Oliveira and C. Constantino and Marques, {H. Pinto} and F. Cardoso",

note = "ok",

year = "2022",

month = sep,

language = "English",

volume = "49",

pages = "S150--S151",

journal = "European Journal Of Nuclear Medicine And Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "SUPPL 1",

}

SUV-based features from baseline 2-[F-18]FDG-PET/CT in breast cancer patients differentiate tumor phenotypes but do not predict pathologic response to neoadjuvant chemotherapy. / Oliveira, C.; Oliveira, F.; Constantino, C. et al.
In: European Journal Of Nuclear Medicine And Molecular Imaging, Vol. 49, No. SUPPL 1, 09.2022, p. S150-S151.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - SUV-based features from baseline 2-[F-18]FDG-PET/CT in breast cancer patients differentiate tumor phenotypes but do not predict pathologic response to neoadjuvant chemotherapy

AU - Oliveira, C.

AU - Oliveira, F.

AU - Constantino, C.

AU - Marques, H. Pinto

AU - Cardoso, F.

N1 - ok

PY - 2022/9

Y1 - 2022/9

M3 - Meeting Abstract

SN - 1619-7070

VL - 49

SP - S150-S151

JO - European Journal Of Nuclear Medicine And Molecular Imaging

JF - European Journal Of Nuclear Medicine And Molecular Imaging

IS - SUPPL 1

ER -